LODOZ

This brand name is authorized in Estonia, France, Hong Kong, Croatia, Italy, Nigeria, Romania, Turkey

Active ingredients

The drug LODOZ contains a combination of these active pharmaceutical ingredients (APIs):

1 Bisoprolol UNII UR59KN573L - BISOPROLOL FUMARATE

Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity. Read about Bisoprolol

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07BB07	Bisoprolol and thiazides	C Cardiovascular system → C07 Beta blocking agents → C07B Beta blocking agents and thiazides → C07BB Beta blocking agents, non-selective, and thiazides
Discover more medicines within C07BB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1137934
Country: FR	Base de données publique des médicaments	Identifier(s): 65118181, 66845664, 67460027
Country: HK	Department of Health Drug Office	Identifier(s): 46865, 49030
Country: IT	Agenzia del Farmaco	Identifier(s): 035583018, 035583069, 035583119
Country: NG	Registered Drug Product Database	Identifier(s): B4-8901, B4-8902, B4-9830
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66295001, W66295002, W66295003, W66296001, W66296002, W66296003, W66297001, W66297002, W66297003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699228090065